Kewaunee Scientific (KEQU) 10-Q 14 Mar 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Jan. 31, 2014	Mar. 10, 2014
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	31-Jan-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Trading Symbol	'KEQU	'
Entity Registrant Name	'KEWAUNEE SCIENTIFIC CORP /DE/	'
Entity Central Index Key	'0000055529	'
Current Fiscal Year End Date	'--04-30	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	2,616,553

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013
Income Statement [Abstract]	'	'	'	'
Net sales	$26,013	$27,450	$84,114	$85,318
Costs of products sold	21,302	22,441	67,934	69,839
Gross profit	4,711	5,009	16,180	15,479
Operating expenses	3,773	4,054	11,676	12,205
Operating earnings	938	955	4,504	3,274
Other income	95	84	265	260
Interest expense	-116	-80	-276	-295
Earnings before income taxes	917	959	4,493	3,239
Income tax expense	292	177	1,505	962
Net earnings	625	782	2,988	2,277
Less: net earnings attributable to the noncontrolling interest	21	238	72	450
Net earnings attributable to Kewaunee Scientific Corporation	$604	$544	$2,916	$1,827
Net earnings per share attributable to Kewaunee Scientific Corporation stockholders	'	'	'	'
Basic	$0.23	$0.21	$1.12	$0.71
Diluted	$0.22	$0.21	$1.11	$0.71
Weighted average number of common shares outstanding	'	'	'	'
Basic	2,615	2,590	2,606	2,586
Diluted	2,645	2,604	2,627	2,596

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013
Statement Of Income And Comprehensive Income [Abstract]	'	'	'	'
Net earnings	$625	$782	$2,988	$2,277
Other comprehensive income (loss), net of tax:	'	'	'	'
Foreign currency translation adjustments	-133	71	-566	46
Change in fair value of cash flow hedge	28	24	70	25
Other comprehensive income (loss)	-105	95	-496	71
Comprehensive income, net of tax	520	877	2,492	2,348
Less: comprehensive income attributable to the noncontrolling interest	21	238	72	450
Comprehensive income attributable to Kewaunee Scientific Corporation	$499	$639	$2,420	$1,898

Consolidated_Statement_of_Stoc

Consolidated Statement of Stockholders' Equity (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
In Thousands
Beginning Balance at Apr. 30, 2013	$31,676	$6,550	$1,567	($305)	$31,191	($7,327)
Purchase of noncontrolling interest (Note B)	-1,874	'	'	'	-1,874	'
Net earnings attributable to Kewaunee Scientific Corporation	2,916	'	'	'	2,916	'
Other comprehensive income (loss)	-496	'	'	'	'	-496
Cash dividends declared, $0.32 per share	-834	'	'	'	-834	'
Stock options exercised, 93,300 shares	1,217	'	-188	1,405	'	'
Stock options granted, 46,600 shares	186	'	186	'	'	'
Purchase of treasury stock, 69,773 shares	-1,158	'	'	-1,158	'	'
Ending Balance at Jan. 31, 2014	$31,633	$6,550	$1,565	($58)	$31,399	($7,823)

Consolidated_Statement_of_Stoc1

Consolidated Statement of Stockholders' Equity (Parenthetical) (USD $)	9 Months Ended
	Jan. 31, 2014
Cash dividends declared, per share	$0.32
Stock options exercised, shares	93,300
Stock options granted, shares	46,600
Treasury stock, shares	69,773
Additional Paid-in Capital [Member]	'
Stock options exercised, shares	93,300
Stock options granted, shares	46,600
Treasury Stock [Member]	'
Stock options exercised, shares	93,300
Treasury stock, shares	69,773
Retained Earnings [Member]	'
Cash dividends declared, per share	$0.32

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Jan. 31, 2014	Apr. 30, 2013
In Thousands, unless otherwise specified
Current Assets:	'	'
Cash and cash equivalents	$6,658	$5,811
Restricted cash	677	691
Receivables, less allowance	21,970	25,884
Inventories	12,507	13,203
Deferred income taxes	601	654
Prepaid expenses and other current assets	1,010	987
Total Current Assets	43,423	47,230
Property, plant and equipment, at cost	46,684	45,109
Accumulated depreciation	-31,818	-30,011
Net Property, Plant and Equipment	14,866	15,098
Deferred income taxes	2,374	2,241
Other	4,300	4,173
Total Other Assets	6,674	6,414
Total Assets	64,963	68,742
Current Liabilities:	'	'
Short-term borrowings and interest rate swap	4,169	6,997
Current portion of long-term debt	421	200
Accounts payable	8,926	10,406
Employee compensation and amounts withheld	1,620	2,076
Deferred revenue	171	488
Other accrued expenses	2,644	1,948
Total Current Liabilities	17,951	22,115
Long-term debt	4,298	3,267
Accrued pension and deferred compensation costs	9,973	9,667
Other non-current liabilities	888	'
Total Liabilities	33,110	35,049
Commitments and Contingencies	'	'
Equity:	'	'
Common Stock	6,550	6,550
Additional paid-in-capital	1,565	1,567
Retained earnings	31,399	31,191
Accumulated other comprehensive loss	-7,823	-7,327
Common stock in treasury, at cost	-58	-305
Total Kewaunee Scientific Corporation Stockholders' Equity	31,633	31,676
Noncontrolling interest	220	2,017
Total Equity	31,853	33,693
Total Liabilities and Equity	$64,963	$68,742

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013
Cash flows from operating activities:	'	'
Net earnings	$2,988	$2,277
Adjustments to reconcile net earnings to net cash provided by operating activities:	'	'
Depreciation	1,846	1,994
Bad debt provision	109	-8
Non-cash stock option expense	186	180
Provision (benefit) for deferred income tax expense	-80	-105
Decrease in receivables	3,805	3,188
Decrease (increase) in inventories	696	-1,128
(Decrease) increase in accounts payable and other accrued expenses	-2,127	157
Decrease in deferred revenue	-317	-423
Other, net	126	-804
Net cash provided by operating activities	7,232	5,328
Cash flows from investing activities:	'	'
Capital expenditures	-1,614	-1,538
Decrease in restricted cash	14	12
Net cash used in investing activities	-1,600	-1,526
Cash flows from financing activities:	'	'
Dividends paid	-834	-784
Dividends paid to noncontrolling interest in subsidiaries	-38	-744
Decrease in short-term borrowings and interest rate swap	-2,828	-4,109
Proceeds from long-term debt	5,000	'
Payments on long-term debt	-3,748	-150
Payments on capital leases	'	-36
Payment toward purchase of noncontrolling interest in subsidiary	-1,780	'
Net proceeds from exercise of stock options (including tax benefit)	59	94
Net cash used in financing activities	-4,169	-5,729
Effect of exchange rate changes on cash	-616	-59
Increase (decrease) in cash and cash equivalents	847	-1,986
Cash and cash equivalents, beginning of period	5,811	6,188
Cash and cash equivalents, end of period	6,658	4,202
Supplemental Disclosure of Cash Flow Information	'	'
Purchase of noncontrolling interest in subsidiary - Other accrued expenses and other non-current liabilities	$1,775	'

Financial_Information

Financial Information	9 Months Ended
	Jan. 31, 2014
Accounting Policies [Abstract]	'
Financial Information	'
	A. Financial Information
	The unaudited interim consolidated financial statements of Kewaunee Scientific Corporation (the “Company”) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”). Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted, although the Company believes that the disclosures are adequate to make the information presented not misleading.
	These interim consolidated financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation of these financial statements and should be read in conjunction with the consolidated financial statements and notes included in the Company’s 2013 Annual Report to Stockholders. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year. The condensed consolidated balance sheet as of April 30, 2013 included in this interim period filing has been derived from the audited financial statements at that date, but does not include all of the information and related notes required by generally accepted accounting principles (GAAP) for complete financial statements.
	The preparation of the interim consolidated financial statements requires management to make certain estimates and assumptions that affect reported amounts and disclosures. Actual results could differ from those estimates.

Purchase_of_Noncontrolling_Int

Purchase of Noncontrolling Interest	9 Months Ended
	Jan. 31, 2014
Noncontrolling Interest [Abstract]	'
Purchase of Noncontrolling Interest	'
	B. Purchase of Noncontrolling Interest
	On June 24, 2013, the Company entered into an Agreement (the “Agreement”) whereby it purchased the 49% minority ownership of its subsidiary, Kewaunee Labway Asia Pte. Ltd. (the “Subsidiary”) for a total purchase price of $3,555,000. The purchase was recorded in the equity section of the consolidated balance sheet as a $1,874,000 reduction in retained earnings and a $1,681,000 reduction in noncontrolling interest. Pursuant to the terms of the Agreement, the Company paid cash of $1,780,000 to the minority stockholder and recorded the balance as other accrued expenses of $887,500 and other non-current liabilities of $887,500. The Subsidiary and its subsidiary in India, Kewanee Labway India Pvt. Ltd., serve as the Company’s principal sales and distribution organization for sales to international customers.

Earnings_Per_Share

Earnings Per Share	9 Months Ended
	Jan. 31, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share	'
	C. Earnings Per Share
	Basic earnings per share is based on the weighted average number of common shares outstanding during the three and nine month periods. Diluted earnings per share reflects the assumed exercise and conversion of outstanding options under the Company’s stock option plans, except when options have an anti-dilutive effect. Options to purchase 36,600 shares were not included in the computation of diluted earnings per share for the three and nine month periods ended January 31, 2014, because the option exercise prices were greater than the average market price of the common shares at that date, and accordingly, such options would have an antidilutive effect. Options to purchase 118,400 shares were not included in the computation of diluted earnings per share for the three and nine month periods ended January 31, 2013, because the effect would be anti-dilutive.

Inventories

Inventories	9 Months Ended
	Jan. 31, 2014
Inventory Disclosure [Abstract]	'
Inventories	'
	D. Inventories
	Inventories consisted of the following (in thousands):
		January 31, 2014		April 30, 2013
	Finished products	$	3,258	$	4,052
	Work in process		1,263		1,678
	Raw materials		7,986		7,473
		$	12,507	$	13,203
	For interim reporting, LIFO inventories are computed based on year-to-date quantities and interim changes in price levels. Changes in quantities and price levels are reflected in the interim consolidated financial statements in the period in which they occur.

LongTerm_Debt_and_Other_Credit

Long-Term Debt and Other Credit Arrangements	9 Months Ended
	Jan. 31, 2014
Debt Disclosure [Abstract]	'
Long-Term Debt and Other Credit Arrangements	'
	E. Long-Term Debt and Other Credit Arrangements
	On May 6, 2013, the Company entered into a new credit and security agreement (the “Loan Agreement”) with a new lender consisting of (1) a $20 million revolving credit facility which matures on May 1, 2016 (“Line of Credit”), (2) a term loan in the amount of $3,450,000 which matures on May 1, 2020 (“Term Loan A”) and (3) a term loan in the amount of $1,550,000 which matures on May 1, 2020 (“Term Loan B” and together with Term Loan A, the “Term Loans”). The Loan Agreement provided funds to refinance all existing indebtedness to the Company’s previous lender and for working capital and other general corporate purposes. In addition, it provides for the issuance of up to $4.7 million of letters of credit for our account. Indebtedness under the Line of Credit bears interest at a variable rate per annum equal to Daily One Month LIBOR plus 1.5% per annum. Payments are due under Term Loan A in consecutive equal monthly principal payments in the amount of $17,000 until August 1, 2017, and then in consecutive equal monthly principal payments in the amount of $79,000 each, commencing on September 1, 2017 and continuing on the first business day of each month thereafter until May 1, 2020, and at that time, all principal, accrued unpaid interest and other charges outstanding under Term Loan A shall be due and payable in full. The interest rate on Term Loan A, after consideration of related interest rate swap agreements, is a fixed rate per annum equal to 4.875%, and effective August 1, 2017, such rate converts to a fixed rate per annum of 4.37%. Payments are due under Term Loan B in consecutive equal monthly principal payments in the amount of $18,000 until May 1, 2020, and at that time, all principal, accrued unpaid interest and other charges outstanding under Term Loan B shall be due and payable in full. The interest rate on Term Loan B, after consideration of the related interest rate swap agreement, is a variable rate per annum equal to Daily One Month LIBOR plus 1.575% per annum, and effective November 3, 2014, such rate converts to a fixed rate per annum of 3.07%.
	The credit facility includes financial covenants with respect to certain ratios, including (a) debt-to-net worth, (b) fixed charge coverage, and (c) asset coverage. At January 31, 2014, the Company was in compliance with all of the financial covenants. At January 31, 2014, there were advances of $3,938,000 outstanding under the revolving credit line.

Segment_Information

Segment Information	9 Months Ended
	Jan. 31, 2014
Segment Reporting [Abstract]	'
Segment Information	'
	F. Segment Information
	The following table provides financial information by business segments for the three and nine months ended January 31, 2014 and 2013 (in thousands):
		Domestic		International		Corporate			Total
		Operations		Operations
	Three months ended January 31, 2014
	Revenues from external customers	$	21,544	$	4,469	$	—		$	26,013
	Intersegment revenues		214		456		(670	)		—
	Earnings (loss) before income taxes		1,227		678		(988	)		917
	Three months ended January 31, 2013
	Revenues from external customers	$	20,445	$	7,005	$	—		$	27,450
	Intersegment revenues		2,415		454		(2,869	)		—
	Earnings (loss) before income taxes		1,009		992		(1,042	)		959
		Domestic		International		Corporate			Total
		Operations		Operations
	Nine months ended January 31, 2014
	Revenues from external customers	$	70,678	$	13,436	$	—		$	84,114
	Intersegment revenues		2,150		1,704		(3,854	)		—
	Earnings (loss) before income taxes		5,791		1,819		(3,117	)		4,493
	Nine months ended January 31, 2013
	Revenues from external customers	$	68,757	$	16,561	$	—		$	85,318
	Intersegment revenues		3,833		1,876		(5,709	)		—
	Earnings (loss) before income taxes		4,331		2,022		(3,114	)		3,239

Defined_Benefit_Pension_Plans

Defined Benefit Pension Plans	9 Months Ended
	Jan. 31, 2014
Compensation And Retirement Disclosure [Abstract]	'
Defined Benefit Pension Plans	'
	G. Defined Benefit Pension Plans
	The Company has non-contributory defined benefit pension plans covering substantially all salaried and hourly employees. These plans were amended as of April 30, 2005, no further benefits have been, or will be, earned under the plans subsequent to the amendment date, and no additional participants will be added to the plans. Contributions of $300,000 were paid to the plans during the nine months ended January 31, 2014, and the Company does not expect any contributions to be paid to the plans during the remainder of the fiscal year. Contributions of $1,000,000 were made during the nine months ended January 31, 2013.
	Pension expense consisted of the following (in thousands):
		Three months ended			Three months ended
		31-Jan-14			January 31, 2013
	Service cost	$	-0-		$	-0-
	Interest cost		214			226
	Expected return on plan assets		(321	)		(303	)
	Recognition of net loss		286			276
	Net periodic pension expense	$	179		$	199
		Nine months ended			Nine months ended
		31-Jan-14			January 31, 2013
	Service cost	$	-0-		$	-0-
	Interest cost		643			679
	Expected return on plan assets		(962	)		(910	)
	Recognition of net loss		857			827
	Net periodic pension expense	$	538		$	596

Reclassifications

Reclassifications	9 Months Ended
	Jan. 31, 2014
Accounting Policies [Abstract]	'
Reclassifications	'
	H. Reclassifications
	Certain 2013 amounts have been reclassified to conform with the 2014 presentation in the consolidated statements of cash flows. Such reclassifications had no impact on net earnings.

Inventories_Tables

Inventories (Tables)	9 Months Ended
	Jan. 31, 2014
Inventory Disclosure [Abstract]	'
Summary of Inventories	'
	Inventories consisted of the following (in thousands):
		January 31, 2014		April 30, 2013
	Finished products	$	3,258	$	4,052
	Work in process		1,263		1,678
	Raw materials		7,986		7,473
		$	12,507	$	13,203

Segment_Information_Tables

Segment Information (Tables)	9 Months Ended
	Jan. 31, 2014
Segment Reporting [Abstract]	'
Segment Information	'
	The following table provides financial information by business segments for the three and nine months ended January 31, 2014 and 2013 (in thousands):
		Domestic		International		Corporate			Total
		Operations		Operations
	Three months ended January 31, 2014
	Revenues from external customers	$	21,544	$	4,469	$	—		$	26,013
	Intersegment revenues		214		456		(670	)		—
	Earnings (loss) before income taxes		1,227		678		(988	)		917
	Three months ended January 31, 2013
	Revenues from external customers	$	20,445	$	7,005	$	—		$	27,450
	Intersegment revenues		2,415		454		(2,869	)		—
	Earnings (loss) before income taxes		1,009		992		(1,042	)		959
		Domestic		International		Corporate			Total
		Operations		Operations
	Nine months ended January 31, 2014
	Revenues from external customers	$	70,678	$	13,436	$	—		$	84,114
	Intersegment revenues		2,150		1,704		(3,854	)		—
	Earnings (loss) before income taxes		5,791		1,819		(3,117	)		4,493
	Nine months ended January 31, 2013
	Revenues from external customers	$	68,757	$	16,561	$	—		$	85,318
	Intersegment revenues		3,833		1,876		(5,709	)		—
	Earnings (loss) before income taxes		4,331		2,022		(3,114	)		3,239

Defined_Benefit_Pension_Plans_

Defined Benefit Pension Plans (Tables)	9 Months Ended
	Jan. 31, 2014
Compensation And Retirement Disclosure [Abstract]	'
Pension Expenses	'
	Pension expense consisted of the following (in thousands):
		Three months ended			Three months ended
		31-Jan-14			January 31, 2013
	Service cost	$	-0-		$	-0-
	Interest cost		214			226
	Expected return on plan assets		(321	)		(303	)
	Recognition of net loss		286			276
	Net periodic pension expense	$	179		$	199
		Nine months ended			Nine months ended
		31-Jan-14			January 31, 2013
	Service cost	$	-0-		$	-0-
	Interest cost		643			679
	Expected return on plan assets		(962	)		(910	)
	Recognition of net loss		857			827
	Net periodic pension expense	$	538		$	596

Purchase_of_Noncontrolling_Int1

Purchase of Noncontrolling Interest - Additional Information (Detail) (USD $)	9 Months Ended		9 Months Ended	0 Months Ended		0 Months Ended
	Jan. 31, 2014	Apr. 30, 2013	Jan. 31, 2014	Jun. 24, 2013	Jan. 31, 2014	Jun. 24, 2013	Jun. 24, 2013
			Retained Earnings [Member]	Kewaunee Scientific Corporation India Pvt. Ltd. [Member]	Kewaunee Scientific Corporation India Pvt. Ltd. [Member]	Kewaunee Scientific Corporation India Pvt. Ltd. [Member]	Kewaunee Scientific Corporation India Pvt. Ltd. [Member]
						Retained Earnings [Member]	Noncontrolling Interest [Member]
Noncontrolling Interest [Line Items]	'	'	'	'	'	'	'
Minority owner ship percentage	'	'	'	49.00%	'	'	'
Total purchase price of minority ownership	'	'	'	$3,555,000	'	'	'
Total purchase price of minority ownership	1,874,000	'	1,874,000	'	'	1,874,000	'
Total purchase price of minority ownership	'	'	'	'	'	'	1,681,000
Cash paid to minority stock holders	1,780,000	'	'	1,780,000	'	'	'
Other accrued expenses	2,644,000	1,948,000	'	'	887,500	'	'
Other non current liabilities recorded	'	'	'	'	$887,500	'	'

Earnings_Per_Share_Additional_

Earnings Per Share - Additional Information (Detail) (Stock Options [Member])	3 Months Ended		9 Months Ended
	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013
Stock Options [Member]	'	'	'	'
Earnings Per Share [Line Items]	'	'	'	'
Antidilutive options exclude from computation of earning per share	36,600	118,400	36,600	118,400

Inventories_Summary_of_Invento

Inventories - Summary of Inventories (Detail) (USD $)	Jan. 31, 2014	Apr. 30, 2013
In Thousands, unless otherwise specified
Inventory Disclosure [Abstract]	'	'
Finished products	$3,258	$4,052
Work in process	1,263	1,678
Raw materials	7,986	7,473
Total inventories	$12,507	$13,203

Recovered_Sheet1

Long-term Debt and Other Credit Arrangements - Additional Information (Detail) (USD $)	0 Months Ended	9 Months Ended
	6-May-13	Jan. 31, 2014
Debt Instrument [Line Items]	'	'
Loan agreement	$20,000,000	'
Letters of credit	4,700,000	'
Interest rate description	'	'Indebtedness under the Line of Credit bears interest at a variable rate per annum equal to Daily One Month LIBOR plus 1.5% per annum
Loan agreement, Maturity date	1-May-16	'
Term Loan A [Member]	'	'
Debt Instrument [Line Items]	'	'
Credit facility outstanding	3,450,000	'
Term loan, Payment terms	'	'Payments are due under Term Loan A in consecutive equal monthly principal payments in the amount of $17,000 until AugustB 1, 2017, and then in consecutive equal monthly principal payments in the amount of $79,000 each, commencing on SeptemberB 1, 2017 and continuing on the first business day of each month thereafter until MayB 1, 2020, and at that time, all principal, accrued unpaid interest and other charges outstanding under Term Loan A shall be due and payable in full.
Fixed rate percentage	4.88%	'
Loan agreement, Maturity date	1-May-20	'
Term Loan A [Member] | August 1, 2017 [Member]	'	'
Debt Instrument [Line Items]	'	'
Periodic payments	17,000	'
Fixed rate percentage	4.37%	'
Term Loan A [Member] | September 1, 2017 [Member]	'	'
Debt Instrument [Line Items]	'	'
Periodic payments	79,000	'
Term Loan B [Member]	'	'
Debt Instrument [Line Items]	'	'
Credit facility outstanding	1,550,000	'
Percentage of interest over one month LIBOR	1.58%	'
Periodic payments	18,000	'
Term loan, Payment terms	'	'Payments in the amount of $18,000 until May 1, 2020, and at that time, all principal
Fixed rate percentage	3.07%	'
Loan agreement, Maturity date	1-May-20	'
Line of Credit [Member]	'	'
Debt Instrument [Line Items]	'	'
Percentage of interest over one month LIBOR	1.50%	'
Revolving Credit Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Credit facility outstanding	'	3,938,000

Segment_Information_Segment_In

Segment Information - Segment Information (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013
Segment Reporting Information [Line Items]	'	'	'	'
Revenues from external customers	$26,013	$27,450	$84,114	$85,318
Intersegment revenues	'	'	'	'
Earnings (loss) before income taxes	917	959	4,493	3,239
Operating Segments [Member] | Domestic Operations [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Revenues from external customers	21,544	20,445	70,678	68,757
Intersegment revenues	214	2,415	2,150	3,833
Earnings (loss) before income taxes	1,227	1,009	5,791	4,331
Operating Segments [Member] | International Operations [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Revenues from external customers	4,469	7,005	13,436	16,561
Intersegment revenues	456	454	1,704	1,876
Earnings (loss) before income taxes	678	992	1,819	2,022
Corporate [Member]	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'
Revenues from external customers	'	'	'	'
Intersegment revenues	-670	-2,869	-3,854	-5,709
Earnings (loss) before income taxes	($988)	($1,042)	($3,117)	($3,114)

Defined_Benefit_Pension_Plans_1

Defined Benefit Pension Plans - Additional Information (Detail) (USD $)	9 Months Ended
	Jan. 31, 2014	Jan. 31, 2013
Compensation And Retirement Disclosure [Abstract]	'	'
Company expected contributions	$0	'
Contributions made by company	$300,000	$1,000,000

Defined_Benefit_Pension_Plans_2

Defined Benefit Pension Plans - Pension Expenses (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013
Compensation And Retirement Disclosure [Abstract]	'	'	'	'
Service cost	$0	$0	$0	$0
Interest cost	214	226	643	679
Expected return on plan assets	-321	-303	-962	-910
Recognition of net loss	286	276	857	827
Net periodic pension expense	$179	$199	$538	$596